dazmegrel has been researched along with Muscle Contraction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dack, KN; Dickinson, RP; Long, CJ; Steele, J | 1 |
1 other study(ies) available for dazmegrel and Muscle Contraction
Article | Year |
---|---|
Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Oral; Animals; Dogs; Drug Design; Enzyme Inhibitors; Imidazoles; Microsomes; Molecular Structure; Muscle Contraction; Phenylpropionates; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Rats; Receptors, Thromboxane; Structure-Activity Relationship; Thromboxane-A Synthase; Thromboxanes | 1997 |